339 related articles for article (PubMed ID: 19318344)
1. Validation of tissue microarray technology in malignant peripheral nerve sheath tumours.
Cunha KS; Caruso AC; Gonçalves AS; Bernardo VG; Pires AR; da Fonseca EC; de Faria PA; da Silva LE; Geller M; de Moura-Neto RS; Lopes VS
J Clin Pathol; 2009 Jul; 62(7):629-33. PubMed ID: 19318344
[TBL] [Abstract][Full Text] [Related]
2. Tissue microarrays compared with whole sections and biochemical analyses. A subgroup analysis of DBCG 82 b&c.
Kyndi M; Sørensen FB; Knudsen H; Overgaard M; Nielsen HM; Andersen J; Overgaard J
Acta Oncol; 2008; 47(4):591-9. PubMed ID: 18465327
[TBL] [Abstract][Full Text] [Related]
3. Validation of tissue microarray technology in endometrioid cancer of the endometrium.
Fons G; Hasibuan SM; van der Velden J; ten Kate FJ
J Clin Pathol; 2007 May; 60(5):500-3. PubMed ID: 16822874
[TBL] [Abstract][Full Text] [Related]
4. A new approach to the validation of tissue microarrays.
Goethals L; Perneel C; Debucquoy A; De Schutter H; Borghys D; Ectors N; Geboes K; McBride WH; Haustermans KM
J Pathol; 2006 Apr; 208(5):607-14. PubMed ID: 16435284
[TBL] [Abstract][Full Text] [Related]
5. Validation of tissue microarray technology in vulvar cancer.
Fons G; van der Velden J; Burger M; ten Kate F
Int J Gynecol Pathol; 2009 Jan; 28(1):76-82. PubMed ID: 19047904
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of S100 protein subtypes in malignant melanoma, and benign and malignant peripheral nerve sheath tumors.
Nonaka D; Chiriboga L; Rubin BP
J Cutan Pathol; 2008 Nov; 35(11):1014-9. PubMed ID: 18547346
[TBL] [Abstract][Full Text] [Related]
7. High-throughput immunophenotyping of 43 ferret lymphomas using tissue microarray technology.
Hammer AS; Williams B; Dietz HH; Hamilton-Dutoit SJ
Vet Pathol; 2007 Mar; 44(2):196-203. PubMed ID: 17317796
[TBL] [Abstract][Full Text] [Related]
8. Tissue microarray validation: a methodologic study with special reference to lung cancer.
Karlsson C; Bodin L; Piehl-Aulin K; Karlsson MG
Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2014-21. PubMed ID: 19531681
[TBL] [Abstract][Full Text] [Related]
9. Tissue microarray for routine analysis of breast biomarkers in the clinical laboratory.
Thomson TA; Zhou C; Chu C; Knight B
Am J Clin Pathol; 2009 Dec; 132(6):899-905. PubMed ID: 19926582
[TBL] [Abstract][Full Text] [Related]
10. Validation of 2-mm tissue microarray technology in gastric cancer. Agreement of 2-mm TMAs and full sections for Glut-1 and Hif-1 alpha.
Berlth F; Mönig SP; Schlösser HA; Maus M; Baltin CT; Urbanski A; Drebber U; Bollschweiler E; Hölscher AH; Alakus H
Anticancer Res; 2014 Jul; 34(7):3313-20. PubMed ID: 24982335
[TBL] [Abstract][Full Text] [Related]
11. Comparison of tissue microarray and full section in immunohistochemistry of gastrointestinal stromal tumors.
Kwon MJ; Nam ES; Cho SJ; Park HR; Shin HS; Park JH; Park CH; Lee WJ
Pathol Int; 2009 Dec; 59(12):851-6. PubMed ID: 20021609
[TBL] [Abstract][Full Text] [Related]
12. Tissue microarray technology in the routine assessment of HER-2 status in invasive breast cancer: a prospective study of the use of immunohistochemistry and fluorescence in situ hybridization.
Graham AD; Faratian D; Rae F; Thomas JS
Histopathology; 2008 Jun; 52(7):847-55. PubMed ID: 18494613
[TBL] [Abstract][Full Text] [Related]
13. Construction of tissue microarrays using pre-existing slides as source of tissue when paraffin blocks are unavailable.
Deng FM; Zhao Y; Kong X; Lee P; Melamed J
J Clin Pathol; 2013 Jul; 66(7):627-9. PubMed ID: 23476078
[TBL] [Abstract][Full Text] [Related]
14. Utility of cytology microarray constructed from effusion cell blocks for immunomarker validation.
Pu RT; Giordano TJ; Michael CW
Cancer; 2008 Oct; 114(5):300-6. PubMed ID: 18798226
[TBL] [Abstract][Full Text] [Related]
15. Validation of usefulness of tissue microarray technology in primary tumours of the canine and feline central nervous system.
Wohlsein P; Recker T; Rohn K; Baumgärtner W
J Comp Pathol; 2012 May; 146(4):320-6. PubMed ID: 22000078
[TBL] [Abstract][Full Text] [Related]
16. Construction of a tissue microarray with two millimeters cores of endometrioid endometrial cancer: factors affecting the quality of the recipient block.
Gottwald L; Sęk P; Piekarski J; Pasz-Walczak G; Kubiak R; Szwalski J; Spych M; Suzin J; Tyliński W; Topczewska-Tylinska K; Jeziorski A
Biotech Histochem; 2012 Nov; 87(8):512-8. PubMed ID: 22909182
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in soft tissue sarcoma. Tissue microarray for immunostaining, the importance of whole-tumor sections and time-dependence.
Engellau J
Acta Orthop Scand Suppl; 2004 Dec; 75(314):2 p preceding table of contents-52, backcover. PubMed ID: 15678700
[TBL] [Abstract][Full Text] [Related]
18. The development and validation of the Virtual Tissue Matrix, a software application that facilitates the review of tissue microarrays on line.
Conway CM; O'Shea D; O'Brien S; Lawler DK; Dodrill GD; O'Grady A; Barrett H; Gulmann C; O'Driscoll L; Gallagher WM; Kay EW; O'Shea DG
BMC Bioinformatics; 2006 May; 7():256. PubMed ID: 16707006
[TBL] [Abstract][Full Text] [Related]
19. Comparative topoisomerase IIa and ki 67 protein expression in papillary thyroid carcinoma based on tissue microarrays and image analysis.
Manaios L; Tsiambas E; Alevizaki M; Karameris A; Alexopoulou D; Lambropoulou S; Moreas H; Kravvaritis C; Fotiades PP; Goula K; Patsouris E; Athanassiou AE; Koutras D; Katsilambros N
J BUON; 2008; 13(4):537-41. PubMed ID: 19145676
[TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of high-throughput small-core (0.6-mm) and large-core (2-mm) thyroid tissue microarray: is larger better?
Jones S; Prasad ML
Arch Pathol Lab Med; 2012 Feb; 136(2):199-203. PubMed ID: 22288969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
